This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Haisco Pharmaceuticals Pte. Ltd., Sichuan Haisco Pharmaceutical Co., Ltd.. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sichuan Province, CN (2021)
- Chengdu, CN (2023)
Company Filing History:
1 out of 3 
1 out of 8 Years Active: 2021-2023
Title: Innovations and Contributions of Zhenggang Huang
Introduction
Zhenggang Huang is a notable inventor based in Province, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various diseases. With a total of two patents to his name, his work has the potential to impact medical treatments significantly.
Latest Patents
Huang's latest patents include "Substituted piperidines as BTK inhibitors" and "Peptide amide compound and preparation method and medical use thereof." The first patent focuses on substituted piperidines, which are compounds used to treat BTK-related diseases such as tumors and autoimmune system diseases. The second patent presents a peptide amide compound with a novel structure that demonstrates better biological activity and analgesic effects.
Career Highlights
Throughout his career, Zhenggang Huang has worked with prominent companies in the pharmaceutical industry, including Haisco Pharmaceuticals Pte. Ltd. and Sichuan Haisco Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas.
Collaborations
Huang has collaborated with several professionals in his field, including Chen Zhang and Jianmin Wang. These partnerships have likely contributed to the success of his inventions and patents.
Conclusion
Zhenggang Huang's work in the pharmaceutical industry showcases his dedication to innovation and improving medical treatments. His patents reflect a commitment to addressing significant health challenges through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile